Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
14.11.24
/
50%
€470.80
Target price
14.11.25
€545.96
Performance (%)
-20.08%
End price
02:15
-
Summary
This prediction is currently being closed. The price of Vertex Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.08%. Citigroup_Inc_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 6.285% | 6.285% | -18.233% |
| iShares Core DAX® | 0.427% | -1.731% | 23.465% |
| iShares Nasdaq 100 | -0.708% | 1.581% | 8.612% |
| iShares Nikkei 225® | -0.388% | 5.241% | 18.501% |
| iShares S&P 500 | -0.351% | 1.309% | 3.539% |
Comments by Citigroup_Inc_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.50
02.10.25
02.10.25
€489.84
02.10.26
02.10.26
8.59%
14.11.25
14.11.25
